UNSPSC 51384504: Carpofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H12CLNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FFL0D546HO. The term carpofen is a European Pharmacopoeia designation. SMILES: CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O.

UNSPSC 51384504 Carpofen, a Commodity code, shows limited recent state and local procurement activity aligned with its nominal pharmaceutical scope. The single recent opportunity in the source—Seminole County, Florida's IFB 60459723LAS—involves procurement of naloxone and drug deactivation systems rather than carpofen itself, indicating a mismatch between the code's intended use and current buying patterns. State and local health departments and county agencies appear to be the primary issuing bodies under this code when activity does occur, though the available record does not establish a pattern of repeat buyers or consistent demand across multiple jurisdictions.

Seminole County's naloxone and drug deactivation systems procurement (IFB posted June 30, 2026, with response due July 26, 2023) calls for 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with one-year renewal option, fixed pricing, and standard compliance requirements including E-Verify, drug-free workplace certification, and insurance coverage. Beyond this single Seminole County opportunity, the source does not support additional recent state and local carpofen or pharmaceutical-goods solicitations. This code shows little relevant current activity in state and local procurement markets.